tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
BioMarin’s Earnings Call: Growth Amid Challenges
PremiumCompany AnnouncementsBioMarin’s Earnings Call: Growth Amid Challenges
1M ago
BioMarin price target lowered to $80 from $90 at Truist
Premium
The Fly
BioMarin price target lowered to $80 from $90 at Truist
1M ago
BioMarin price target lowered to $66 from $70 at RBC Capital
Premium
The Fly
BioMarin price target lowered to $66 from $70 at RBC Capital
1M ago
BioMarin price target lowered to $102 from $103 at BofA
PremiumThe FlyBioMarin price target lowered to $102 from $103 at BofA
1M ago
BioMarin price target lowered to $55 from $60 at H.C. Wainwright
Premium
The Fly
BioMarin price target lowered to $55 from $60 at H.C. Wainwright
1M ago
BioMarin Pharmaceutical: Strong Growth Potential Amidst Competitive Challenges
Premium
Ratings
BioMarin Pharmaceutical: Strong Growth Potential Amidst Competitive Challenges
1M ago
BioMarin’s BMN 349 Study: A New Hope for Alpha 1-Antitrypsin Deficiency
PremiumCompany AnnouncementsBioMarin’s BMN 349 Study: A New Hope for Alpha 1-Antitrypsin Deficiency
1M ago
BioMarin lowers 2025 non-GAAP EPS view to $3.50-$3.60 from $4.40-$4.55
Premium
The Fly
BioMarin lowers 2025 non-GAAP EPS view to $3.50-$3.60 from $4.40-$4.55
1M ago
BioMarin reports Q3 adjusted EPS 12c, consensus 7.6c
Premium
The Fly
BioMarin reports Q3 adjusted EPS 12c, consensus 7.6c
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100